about
Conservative tryptophan mutants of the protein tyrosine phosphatase YopH exhibit impaired WPD-loop function and crystallize with divanadate esters in their active sitesRecent advances into vanadyl, vanadate and decavanadate interactions with actin.Characterization of aqueous formulations of tetra- and pentavalent forms of vanadium in support of test article selection in toxicology studies.Use of antimony in the treatment of leishmaniasis: current status and future directions.DNA-Binding and Topoisomerase-I-Suppressing Activities of Novel Vanadium Compound Van-7Vanadium and bone development: putative signaling pathways.Vanadium-induced apoptosis of HaCaT cells is mediated by c-fos and involves nuclear accumulation of clusterin.X-ray fluorescence microscopy demonstrates preferential accumulation of a vanadium-based magnetic resonance imaging contrast agent in murine colonic tumors.Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes.New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive Compounds.Characterization and cytotoxic effect of aqua-(2,2',2''-nitrilotriacetato)-oxo-vanadium salts on human osteosarcoma cells.Anticancer activity of metal complexes: involvement of redox processes.Selenium interactions and toxicity: a review. Selenium interactions and toxicity.Recent perspectives into biochemistry of decavanadate.An evidence-based systematic review of vanadium by the Natural Standard Research Collaboration.The potentiality of vanadium in medicinal applications.Vanadium Compounds as Pro-Inflammatory Agents: Effects on Cyclooxygenases.Vanadium(III)-l-cysteine enhances the sensitivity of murine breast adenocarcinoma cells to cyclophosphamide by promoting apoptosis and blocking angiogenesis.Perspectives for vanadium in health issues.In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice.Bis(acetylacetonato)-oxidovanadium(IV) and sodium metavanadate inhibit cell proliferation via ROS-induced sustained MAPK/ERK activation but with elevated AKT activity in human pancreatic cancer AsPC-1 cells.Vanadate-induced antiproliferative and apoptotic response in esophageal squamous carcinoma cell line EC109.Deciphering the effect of an oxovanadium(iv) complex with the flavonoid chrysin (VOChrys) on intracellular cell signalling pathways in an osteosarcoma cell line.An oxovanadium(IV) complex protects murine bone marrow cells against cisplatin-induced myelotoxicity and DNA damage.Anticancer metal complexes: synthesis and cytotoxicity evaluation by the MTT assay.Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model.The endoplasmic reticulum mitochondrial calcium cross talk is downregulated in malignant pleural mesothelioma cells and plays a critical role in apoptosis inhibition.Physicochemical properties of ternary oxovanadium(IV) complexes with oxydiacetate and 1,10-phenanthroline or 2,2'-bipyridine. Cytoprotective activity in hippocampal neuronal HT22 cells.Geochemistry of vanadium (V) in Chinese coals.Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.Antitumor properties of a vanadyl(IV) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis.Therapeutic potential of a pyridoxal-based vanadium(IV) complex showing selective cytotoxicity for cancer versus healthy cells.Hydroxylamido-amino acid complexes of oxovanadium(V). Toxicological study in cell culture and in a zebrafish model.Spectroscopic characterization of an oxovanadium(IV) complex of oxodiacetic acid and o-phenanthroline. Bioactivity on osteoblast-like cells in culture.Cellular responses of osteoblast-like cells to 17 elemental metals.Cellular uptake of a fluorescent vanadyl sulfonylcalix[4]arene.Jeju ground water containing vanadium enhances antioxidant systems in human liver cells.Cyto- and genotoxicity of a vanadyl(IV) complex with oxodiacetate in human colon adenocarcinoma (Caco-2) cells: potential use in cancer therapy.Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium(IV)/silibinin complex.Brain Metal Distribution and Neuro-Inflammatory Profiles after Chronic Vanadium Administration and Withdrawal in Mice.
P2860
Q28829658-50E79EA9-F3DD-403F-A8D3-8AE9C953835CQ30408403-C6A162C7-3369-41D3-A47D-32909FEE618CQ31135989-15B4C0E2-FA23-477F-B0F2-C961EE457E45Q35377767-0532A1D2-CC25-408D-9861-EAF88DA71644Q36302299-F75FA0C1-DC02-4172-8283-47E0962D0241Q36602608-C2EABD96-B8C8-4A53-B7B6-835C6E20451CQ36735217-0F304F1D-7670-49C0-AC9E-6766F0F4B3C2Q36820098-C9590530-5CF4-430D-9C56-C6D5C7544A56Q37115673-D5EDA7C2-37C6-4FCA-A0E3-773A028B6B3DQ37697414-2FC20CFD-7A04-4136-9740-D728B864FFFFQ37703251-DC27AED3-28D0-459B-ACDB-40677D015875Q37833099-00705162-9ABF-4384-B705-556B3DD14A43Q37931095-B455390C-6A26-4CE0-B8BD-CF426DB40C8FQ37949967-69ECCA40-004C-41AF-9390-3919C98ECBA6Q38034568-BF9B7AED-D6C3-42E0-8B16-EB134DBFBD04Q38050178-A73719F7-79A2-47DE-8DCA-39F1099D1411Q38520262-6FB33F11-BEA3-4EB4-ADCD-CE233328143CQ38705101-200752F7-1854-43E1-A273-F56CAED602BFQ38742665-5E405C47-47A3-4054-A069-DE6D3A1BF073Q38742783-89505B13-7C0B-4C1A-B653-F24A3F1FF04EQ38747030-41DD0DC5-5FC0-4AE4-861C-2049E895A77DQ38747993-27DD0C0D-7DC1-41E3-BB1B-80169C88A811Q38771349-3AED6333-F8C0-4C1D-B609-6FA2B9AC98D1Q38792860-DD52BF40-3087-474C-83C9-4F66E47079F8Q38795822-6DCF5A5F-790E-449C-82E7-BDF3F211C57AQ38832743-50978A13-036E-4DDA-9DC8-FAF5979706C1Q38855303-8E7D10E0-38A1-4B06-AE78-119ADD9CD942Q38912513-1E79FB41-E96B-467F-88CE-75CACE2F05AEQ38978433-805BA74C-4932-4F42-8E4C-8E4FB124317EQ39063063-FFF55846-D13C-4EBC-BEFB-9A3697FE80FDQ39140333-5BB3C287-F7B9-4573-B71C-13DBD699EDB3Q39165899-4458CF4B-5F94-4E92-B269-D85B88637416Q39257926-53542DA8-5727-413A-A244-2CE8C9E46E06Q39411867-5A699382-0D41-413F-97B9-BFD6199D9ADDQ39416402-43C4A9D9-A75A-46B8-9EFC-4C07892968E6Q39429961-C8F4C737-2596-42B3-9B3D-4BF5D9FA0378Q39434278-3C391385-3148-4619-9C3C-612A6F0F6B80Q39507085-CBE10BE1-9361-4731-AE42-2790917C4C68Q39576784-A3ABC250-A50E-41AC-A169-2E81427D0EBEQ41108059-51EE2F49-1855-40BB-BEF8-332889B6D612
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Vanadium in cancer treatment.
@ast
Vanadium in cancer treatment.
@en
Vanadium in cancer treatment.
@nl
type
label
Vanadium in cancer treatment.
@ast
Vanadium in cancer treatment.
@en
Vanadium in cancer treatment.
@nl
prefLabel
Vanadium in cancer treatment.
@ast
Vanadium in cancer treatment.
@en
Vanadium in cancer treatment.
@nl
P1476
Vanadium in cancer treatment.
@en
P2093
Angelos M Evangelou
P304
P356
10.1016/S1040-8428(01)00221-9
P577
2002-06-01T00:00:00Z